Loading...
Medical Data Vision Co., Ltd.
3902.T•JPX
Healthcare
Medical - Healthcare Information Services
¥517.00
¥0.00(0.00%)
Medical Data Vision Co., Ltd. (3902.T) Financial Performance & Income Statement Overview
Review Medical Data Vision Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-7.98%
↓ 7.98%
Operating Income Growth
-99.79%
↓ 99.79%
Net Income Growth
-180.80%
↓ 180.80%
Operating Cash Flow Growth
-154.31%
↓ 154.31%
Operating Margin
-0.48%
↓ 0.48%
Gross Margin
72.23%
↑ 72.23%
Net Profit Margin
-12.62%
↓ 12.62%
ROE
-22.41%
↓ 22.41%
ROIC
-0.94%
↓ 0.94%
Medical Data Vision Co., Ltd. (3902.T) Income Statement & Financial Overview
Review Medical Data Vision Co., Ltd.'s (3902.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.78B | $1.34B | $1.39B | $1.39B |
| Cost of Revenue | $505.00M | $352.00M | $376.47M | $342.96M |
| Gross Profit | $1.28B | $993.00M | $1.02B | $1.05B |
| Gross Profit Ratio | $0.72 | $0.74 | $0.73 | $0.75 |
| R&D Expenses | $0.00 | $0.00 | $51.31M | $129.52M |
| SG&A Expenses | $1.13B | $1.16B | $990.66M | $862.43M |
| Operating Expenses | $1.13B | $1.16B | $1.04B | $991.95M |
| Total Costs & Expenses | $1.64B | $1.51B | $1.42B | $1.33B |
| Interest Income | $0.00 | $0.00 | $0.00 | $14000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $31.75M | $25.25M | $24.77M | $19.14M |
| EBITDA | $175.75M | -$142.75M | -$1.77M | $53.65M |
| EBITDA Ratio | $0.10 | -$0.11 | -$0.001 | $0.04 |
| Operating Income | $143.00M | -$166.00M | -$26.55M | $53.66M |
| Operating Income Ratio | $0.08 | -$0.12 | -$0.02 | $0.04 |
| Other Income/Expenses (Net) | -$515.00M | -$157.00M | -$28.32M | -$30.82M |
| Income Before Tax | -$372.00M | -$323.00M | -$54.87M | $22.83M |
| Income Before Tax Ratio | -$0.21 | -$0.24 | -$0.04 | $0.02 |
| Income Tax Expense | $115.00M | $97.00M | $18.46M | $40.20M |
| Net Income | -$477.00M | -$228.00M | -$71.09M | -$15.53M |
| Net Income Ratio | -$0.27 | -$0.17 | -$0.05 | -$0.01 |
| EPS | -$12.54 | -$5.97 | -$1.86 | -$0.41 |
| Diluted EPS | -$12.54 | -$5.97 | -$1.86 | -$0.41 |
| Weighted Avg Shares Outstanding | $38.05M | $38.20M | $38.20M | $38.20M |
| Weighted Avg Shares Outstanding (Diluted) | $38.05M | $38.20M | $38.20M | $38.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan